company background image
531686 logo

MPS Pharmaa BSE:531686 Stock Report

Last Price

₹3.21

Market Cap

₹61.3m

7D

0%

1Y

52.9%

Updated

26 Apr, 2024

Data

Company Financials

531686 Stock Overview

MPS Pharmaa Limited manufactures, markets, trades in, and exports pharmaceutical products.

531686 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

MPS Pharmaa Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MPS Pharmaa
Historical stock prices
Current Share Price₹3.21
52 Week High₹3.21
52 Week Low₹2.10
Beta-0.14
1 Month Change0%
3 Month Changen/a
1 Year Change52.86%
3 Year Change217.82%
5 Year Change73.51%
Change since IPO-72.42%

Recent News & Updates

Recent updates

Shareholder Returns

531686IN PharmaceuticalsIN Market
7D0%1.4%2.8%
1Y52.9%57.2%46.6%

Return vs Industry: 531686 underperformed the Indian Pharmaceuticals industry which returned 57.2% over the past year.

Return vs Market: 531686 exceeded the Indian Market which returned 46.6% over the past year.

Price Volatility

Is 531686's price volatile compared to industry and market?
531686 volatility
531686 Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.9%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 531686 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 531686's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
199418Peeyush Aggarwalwww.mpspharmaa.com

MPS Pharmaa Limited manufactures, markets, trades in, and exports pharmaceutical products. The company offers generic products, including antibacterials, antiallergics, antifungals, anthelminthics, antihypertensives, antimalarials, antituberculosis, corticosteroids, erectile dysfunction, gastrointestinal agents, sedatives, and others, as well as analgesic, antipyretic, and anti-inflammatory products. It also offers ethical products.

MPS Pharmaa Limited Fundamentals Summary

How do MPS Pharmaa's earnings and revenue compare to its market cap?
531686 fundamental statistics
Market cap₹61.35m
Earnings (TTM)-₹9.02m
Revenue (TTM)₹1.15m

53.5x

P/S Ratio

-6.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
531686 income statement (TTM)
Revenue₹1.15m
Cost of Revenue₹2.09m
Gross Profit-₹943.71k
Other Expenses₹8.08m
Earnings-₹9.02m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.47
Gross Margin-82.35%
Net Profit Margin-787.51%
Debt/Equity Ratio290.5%

How did 531686 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.